UK markets closed

MorphoSys AG (MOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.4600-0.1700 (-3.67%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
195,096
179,612
327,698
71,755
76,443
Cost of revenue
42,145
32,195
9,174
12,085
1,797
Gross profit
152,951
147,417
318,524
59,670
74,646
Operating expenses
Research development
277,352
225,211
141,427
108,432
106,397
Selling general and administrative
129,713
154,220
159,146
59,336
28,310
Total operating expenses
452,675
425,041
300,573
167,768
134,554
Operating income or loss
-299,724
-277,624
17,952
-108,098
-59,908
Interest expense
277,023
65,824
96,214
2,272
179
Total other income/expenses net
-252,194
-245,114
8,708
1,050
-434
Income before tax
-931,011
-591,050
22,492
-106,520
-60,476
Income tax expense
-79,623
-76,591
-75,399
-3,506
-4,305
Income from continuing operations
-851,388
-514,460
97,891
-103,014
-56,172
Net income
-851,388
-514,460
97,891
-103,014
-56,172
Net income available to common shareholders
-851,388
-514,460
97,891
-103,014
-56,172
Basic EPS
-
-3.85
0.75
-0.81
-0.45
Diluted EPS
-
-3.85
0.74
-0.81
-0.45
Basic average shares
-
133,636
130,103
126,445
125,356
Diluted average shares
-
133,636
132,671
126,445
125,356
EBITDA
-
-515,135
127,036
-98,003
-56,547